Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH ...
Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...
Maintaining a healthy blood sugar level can reduce your disease risk and give you more energy. These 15 habits help keep ...
Merck & Co., Inc. acquires Cidara Therapeutics, Inc. for $9.2bn, boosting its pipeline with CD388's strong flu data. Click ...
The drug enlicitide reduced cholesterol for adults with high levels due to an inherited disorder and may also work for a broader population.
Upending previous research, study finds no evidence of status-quo bias favoring standard care when two or more appropriate alternatives are presented.
New research reveals that tirzepatide and semaglutide both offer strong, early heart-protective effects. A major new ...
FDA Alignment -- BioAtla ( BCAB 4.08%) achieved FDA alignment on phase three trial design, dosing, comparator, and endpoints ...
CARDIAMP CMI Cohort Results -- In the open-label rolling cohort (n=5), patients saw an average 80-second increase in exercise ...
The American Academy of Pediatrics declined to recommend routine use of leucovorin for children with autism spectrum disorder ...
A major clinical trial shows that a conservative, indication-based dialysis strategy improves kidney recovery and reduces ...
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results